Evoq Technologies is excited to announce the FDA registration of the first in its family of products based on its proprietary smartphone-based biosensor technology. Dubbed the ‘SmartERG’ Platform, it’s built to test the eye’s retinal health in unique ways. About the science: By flashing a controlled light at the eye, we can evoke an electrical-physiological response from the retina that …
Novel digital therapy for amblyopia demonstrates positive phase 3 results
Luminopia One, an investigational digital therapy that allows patients with amblyopia to watch visually modified TV shows and movies to improve vision, has shown positive results, according to a press release from Luminopia. The phase 3 multicenter, randomized, controlled pivotal clinical trial, published in Ophthalmology, was designed to test the safety and efficacy of Luminopia One in patients with amblyopia aged …
Complexity Gaming Kicks Off Year-Long Partnership With Alcon
Esports company Complexity Gaming announced a partnership with Alcon. The partnership will designate Alcon’s signature brand of lubricant eye drops, Systane, as the first official eye care partner of Complexity Gaming.
Eyeque Announces Series C Closing With More Than $57 Million in Capital Raised
EyeQue announced that they have closed a Series C round and have raised more than $57 million in capital since the company was founded in 2015. EyeQue aims to bring affordable vision correction with their smartphone vision tests. The company has developed a suite of at-home vision tests using optical smartphone attachments that consumers can use to self-administer a refractive …
AI-based eye test could help prevent severe vision loss
Researchers from Imperial College London and University College London (UCL) carried out a clinical trial using retinal imaging technology known as Detection of Apoptosis in Retinal Cells (DARC). When tested on 113 patients in the trial, the technology was able to identify areas of the eye that were showing signs of geographic atrophy (GA) – a common condition that causes …
Berlin’s Dopavision raises €12M to halt myopia progression in children and adolescents; here’s how
Dopavision is a Berlin-based company developing digital therapeutics for myopia. Nearsightedness (myopia) is a vision condition in which patients can see objects near to them clearly, but objects farther away are blurry.Dopavision raises Series A roundIn a recent development, the company announced that it has raised €12M in its Series A round of funding. The round was led by Seventure …
New telemedicine approach may allow for remote treatment of DR
A novel telemedicine approach combining the high speed of 5G wireless networks and navigated retinal laser photocoagulation could allow treatment of diabetic retinopathy at a distance.
Rayner Announces 1,000 IOLs Recorded on RayPRO Digital Platform
Rayner announced that it has achieved the milestone figure of 1,000 intraocular lenses recorded on RayPRO, its digital patient reported outcomes platform.
